corgenix Message Board - Msg: 24280907

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : corgenix

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: RikRichter	2/4/2008 11:03:48 AM
	of 191

Corgenix to Host Conference Call to Discuss Second Quarter Fiscal 2008 Results Monday February 4, 10:37 am ET DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTCBB:CONX - News), a worldwide developer and marketer of diagnostic test kits, will host a conference call on Thursday, February 14, 2008 at 11:00 AM EST to discuss the Company's financial and operating performance for its second quarter 2008 and the status of the Company's product development and marketing activities. Corgenix invites all those interested in hearing management's discussion of the quarter results to join the call by dialing: US attendees: (800) 895-0198 International attendees: +1 785 424 1053 Conference code is: CORGENIX A question and answer session will follow the presentation by Corgenix management. A replay will be available for 30 days following the call by dialing (800) 727-6189 for US participants and +1 402 220 2671 for international participants. About Corgenix Medical Corporation Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA process. More information is available at www.corgenix.com. Contact: Corgenix Medical Corp. William Critchfield, 303-453-8903 Senior VP and CFO wcritchfield@corgenix.com or Armada Medical Marketing Dan Snyders, 303-623-1190 ext. 230 Vice President, Public Relations Supervisor dan@armadamedical.com -------------------------------------------------------------------------------- Source: Corgenix Medical Corporation

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next